Prova Education

Prova Education

By ReachMDMedicine
Download on the App Store

Prova Education episodes

  • What’s New About Gout? Rheumatology Perspective
    Host: Richard Johnson, MD
    Guest: John K. Botson, MD, RPh

    This activity is no longer available for continuing education credit.

    Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and metabolic syndrome. Tune in to find out how to incorporate targeted therapies when managing uncontrolled refractory gout and improve your patients’ quality of life.

    5 min
  • Treat or Refer: Who Is Responsible for Managing Gout?
    Host: John K. Botson, MD, RPh
    Guest: Abdul Abdellatif, MD, FASN

    This activity is no longer available for continuing education credit.

    Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and metabolic syndrome. Tune in to find out how to incorporate targeted therapies when managing uncontrolled refractory gout and improve your patients’ quality of life.

    5 min
  • Gout Beyond the Joints: What’s the Hidden Danger?
    Host: Richard Johnson, MD

    This activity is no longer available for continuing education credit.

    Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and metabolic syndrome. Tune in to find out how to incorporate targeted therapies when managing uncontrolled refractory gout and improve your patients’ quality of life.

    4 min
  • What Are the Emerging Therapies for Managing Gout?
    Host: Richard Johnson, MD
    Guest: John K. Botson, MD, RPh

    This activity is no longer available for continuing education credit.

    Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and metabolic syndrome. Tune in to find out how to incorporate targeted therapies when managing uncontrolled refractory gout and improve your patients’ quality of life.

    5 min
  • What’s New About Gout? Nephrology Perspective
    Host: Abdul Abdellatif, MD, FASN
    Guest: Richard Johnson, MD

    This activity is no longer available for continuing education credit.

    Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and metabolic syndrome. Tune in to find out how to incorporate targeted therapies when managing uncontrolled refractory gout and improve your patients’ quality of life.

    5 min
  • Can You Manage Patients With Uncontrolled Gout More Effectively?
    Host: Abdul Abdellatif, MD, FASN
    Guest: John K. Botson, MD, RPh

    This activity is no longer available for continuing education credit.

    Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and metabolic syndrome. Tune in to find out how to incorporate targeted therapies when managing uncontrolled refractory gout and improve your patients’ quality of life.

    5 min
  • Is Managing Gout in the Nephrology Clinic a Challenge?
    Host: Richard Johnson, MD
    Guest: Abdul Abdellatif, MD, FASN

    This activity is no longer available for continuing education credit.

    Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and metabolic syndrome. Tune in to find out how to incorporate targeted therapies when managing uncontrolled refractory gout and improve your patients’ quality of life.

    5 min
  • Should We Look for Gout in the Cardiology Clinic?
    Host: Richard Johnson, MD
    Guest: Brittany Weber, MD, PhD

    This activity is no longer available for continuing education credit.

    Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and metabolic syndrome. Tune in to find out how to incorporate targeted therapies when managing uncontrolled refractory gout and improve your patients’ quality of life.

    4 min
  • Is Gout Hiding in the Nephrology Clinic?
    Host: Abdul Abdellatif, MD, FASN
    Guest: Richard Johnson, MD

    This activity is no longer available for continuing education credit.

    Conventional oral urate-lowering therapies frequently to fail to achieve target serum uric acid (sUA) levels in patients with chronic kidney disease and uncontrolled refractory gout. This can lead to increased urate burden and complications, including worsening kidney disease, cardiovascular events, and metabolic syndrome. Tune in to find out how to incorporate targeted therapies when managing uncontrolled refractory gout and improve your patients’ quality of life.

    5 min

About Prova Education

From the publisher's feed

Prova Education designs educational programs that address a broad spectrum of gaps in awareness, attitudes, skills, and competencies related to guideline-based care and evolving disease management…